Welcome to our dedicated page for INSTITUTE OF BIOMED RESH news (Ticker: $MRES), a resource for investors and traders seeking the latest updates and insights on INSTITUTE OF BIOMED RESH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect INSTITUTE OF BIOMED RESH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of INSTITUTE OF BIOMED RESH's position in the market.
Rhea-AI Summary
Institute of Biomedical Research Corp. (MRES) announces stellar growth in 2023 with the M2Bio Food and Beverage division. The company expanded its product range, entered new markets, and formed strategic partnerships, setting the stage for further expansion in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
-
Rhea-AI Summary
In March 2024, the Institute of Biomedical Research Corporation (MRES) finalized the sale of 100% ownership of M2MMA to Real American Capital Corporation (RLAB) through a share-based settlement. MRES is projected to hold approximately 71% of RLAB's fully diluted shares, with 56,368,000 outstanding shares. MRES's CEO and CFO have been appointed as Chairman and CFO of RLAB. MRES also disclosed collaborations with Innovative Holdings Alliance Inc. for distribution in the USA and the University of Pretoria for AI-driven phytomedicine research.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
M2Bio Sciences launches M2BioKids, a pioneering division dedicated to enhancing mental and physical health in children aged five and under. M2BioKids focuses on nutritional science, physical development, and mental/cognitive enhancement through innovative AI-driven solutions. The initiative aims to revolutionize early childhood development, addressing global undernutrition challenges and offering evidence-based solutions for optimal growth and health. CEO Jeff Robinson emphasizes the commitment to leveraging AI and biotechnological innovations to create a healthier, more intellectually capable generation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.76%
Tags
Rhea-AI Summary
Institute of Biomedical Research Corp. (MRES) announces M2Enviro updates focusing on mycelium technology and sustainable packaging solutions. The company achieved breakthroughs in 2023 with Hempcelium™, a biodegradable packaging solution. M2Enviro plans to expand its operations in 2024 with a strong emphasis on research & development and the advancement of Hempcelium™. The company aims to meet the growing demand for its eco-friendly products through the construction of a new production facility and targeted marketing campaigns.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
-
Rhea-AI Summary
Institute of Biomedical Research Corp. announces updates for its M2Biome division, focusing on nutraceutical biotechnology, plant-based cannabinoids, and mental health research. The division achieved significant growth in 2023, launching a website, providing nutritional information, recipes, and educational content. They plan to delve deeper into gut health in 2024 and develop products like premium black garlic and nutritional bars. The division aims to revolutionize nutrition with AI-driven personalized nutrition recommendations and a groundbreaking M2Biome App in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
-
Rhea-AI Summary
Real American Capital Corporation (RLAB) has acquired 100% ownership of the concept, business model, contacts, and contracts from Institute of Biomedical Research Corporation (MRES) to establish a mixed martial arts league called 'M2MMA'. The transaction will be settled entirely in shares, resulting in a change of control of RLAB. Jeff Robinson and Willem Jonker, CEO and CFO of MRES, have been appointed Chairman and Chief Financial Officer of RLAB. Doug Newton, outgoing co-CEO of RLAB, has a lifelong connection to martial arts and supports the exciting innovations Jeff and his team are bringing to the sport.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.6%
Tags
Rhea-AI Summary
Institute of Biomedical Research Corp. (MRES) announces M2MMA division's international expansion in 2024, highlighting its achievements in 2023 and the appointment of Chris Cannon as General Manager. The company is focused on global promotions, new partnerships, and maintaining a health-focused approach in the sports community.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.65%
Tags
-
Rhea-AI Summary
Institute of Biomedical Research Corp. (MRES): M2Bio Sciences Expands into Dubai Science Park, positioning itself at the forefront of global biotechnology and fintech. The company's strategic move reflects a commitment to fostering collaboration and innovation in the international landscape of nutraceutical biotechnology and AI-driven research.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
-
Rhea-AI Summary
Institute of Biomedical Research Corp. (MRES) announces the expansion of M2Bio Sciences Food & Beverage, a leader in nutraceutical biotechnology, opening offices in Los Angeles, California. The move aims to broaden the distribution of Liviana™ and Medspresso™ products within the United States, aligning with the company's global commitment to providing healthy and trusted food products. M2Bio is set to collaborate with Rand Capital Coffee, expanding its presence in the food and beverage industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.65%
Tags
Rhea-AI Summary
Institute of Biomedical Research Corp. (OTC PINK:MRES) held the Annual Biomedical Research & Innovation Platform Symposium. Prof Vinesh Maharaj discussed the potential of plant-based medicine and the use of artificial intelligence in drug development. The University of Pretoria is working on establishing a comprehensive plant database and high-throughput screening method. They have found African ginger to be effective against SARS-CoV-2 and influenza. The university has filed a patent for using African ginger in the fight against COVID-19.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.67%
Tags
INSTITUTE OF BIOMED RESH
OTC:MRES
MRES Rankings
MRES Stock Data
About MRES
institute of biomedical research corp is a company based out of montenegro.